Molecular Markes of Fibrosis of Endometriosis and Their Use in Predicting Disease Severity
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-45
SponsorGeneral University Hospital, Prague
About this trial
The primary aim of the project is to analyse gene expression in individual types of ectopic endometrium (ovarian endometriosis, peritoneal endometriosis, deep infiltrating endometriosis) and compare it with gene expression in eutopic endometrium. The analysis focuses on the identification of genes with significantly increased expression in each type of ectopic endometrium and comparison of their expression with the degree of disease, ovarian reserve and clinical manifestations of the disease (pain, infertility).
Eligibility criteria
Qualifiers
women (18-45 years)
signed informed consent with the study
absence of hormonal treatment 3 months before the planned procedure
patients without endometriosis
Disqualifiers
absence of informed consent
patients who do not meet the inclusion criteria during surgery
patient younger than 18 years of age or older than 45 years of age
Trial design
Treatments tested in this trial
- Molecular markes of fibrosis of single types of endometriosis and their use in predicting disease severity
Treatment groups
120 Participants
are divided into 4 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov